Buserelin Acetate
Synthetic GnRH Agonist for Oncology and Reproductive Health
Buserelin Acetate is a potent synthetic peptide analog of gonadotropin-releasing hormone (GnRH). By modulating the production of pituitary gonadotropins, it effectively regulates estrogen and testosterone levels, making it a cornerstone therapy in gynecology, oncology, and pediatric endocrinology.
Clinical Indications
Suppresses estrogen to reduce ectopic endometrial growth, alleviating pelvic pain and infertility.
Reduces estrogenic stimulation to shrink myomas and relieve heavy menstrual bleeding or anemia.
Inhibits sex-steroid synthesis to slow the progression of hormone-sensitive malignancies.
Pediatric Application
Central Precocious Puberty: Buserelin Acetate is instrumental in arresting premature hormonal activity in children, allowing for age-appropriate physiological and skeletal development.
Contraindications
While highly effective, Buserelin Acetate is contraindicated for individuals meeting the following criteria:
Hypersensitivity
▸ Known allergy to Buserelin Acetate or LH-RH derivatives.
▸ History of severe reactions to synthetic LH/RH analogs.
Pregnancy & Lactation
▸ Pregnant women or those suspecting pregnancy (fetal risk).
▸ Breastfeeding mothers.
Therapy must not be initiated in patients with undiagnosed vaginal bleeding. A thorough clinical investigation is required to rule out underlying malignancies or serious physiological conditions before beginning Buserelin treatment.
Global Peptide Solutions
Origin Biotech provides high-purity Buserelin Acetate API and comprehensive technical support for global pharmaceutical development.